These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2652223)
1. Effect of thymopentin on the anaemia of myelodysplastic syndromes. A preliminary study. Catarini M; Sebastianelli G; Romagnoli R; Leoni P Recenti Prog Med; 1989 Jan; 80(1):46. PubMed ID: 2652223 [No Abstract] [Full Text] [Related]
2. Effects of thymopentin on the anaemia of chronic lymphoproliferative disorders. Paladini G; Tosato F Haematologica; 1986; 71(6):519-20. PubMed ID: 3104165 [No Abstract] [Full Text] [Related]
3. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results]. Garozzo G; Granà G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223 [No Abstract] [Full Text] [Related]
5. Thymopentin in the treatment of alopecia areata. Orecchia G Dermatologica; 1989; 178(4):231. PubMed ID: 2670621 [No Abstract] [Full Text] [Related]
6. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome. Hamilton G; Zöch G; Rath T; Meissl G Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748 [No Abstract] [Full Text] [Related]
7. [Use of thymopentin in the therapy of recurrent oral ulcers]. Robotti MP; Fabbri G; Baldin C; Faccioli G; Ciaffoni S Minerva Stomatol; 1988 Jun; 37(6):497-503. PubMed ID: 3050443 [No Abstract] [Full Text] [Related]
8. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. Levinsky RJ; Davies EG; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239 [No Abstract] [Full Text] [Related]
9. Thymopentin in dermatology. Haneke E Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371 [No Abstract] [Full Text] [Related]
10. [Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis]. Salvati F Recenti Prog Med; 1989 Sep; 80(9):499. PubMed ID: 2687987 [No Abstract] [Full Text] [Related]
11. [Correction of lipid peroxidation in stress with the peptide bioregulator thymopentin]. Deviatkina TA; Brechko VV; Tarasenko LM; Zviago'lskaia IN; Bezuglyĭ IuV; Rituma IR; Klusha VE Fiziol Zh (1978); 1989; 35(5):14-8. PubMed ID: 2687033 [TBL] [Abstract][Full Text] [Related]
12. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies. Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238 [No Abstract] [Full Text] [Related]
13. [Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)]. Auteri A; D'Aniello C; Falotico N; Saletti M; Di Perri T Recenti Prog Med; 1986 Sep; 77(9):423-8. PubMed ID: 3541085 [No Abstract] [Full Text] [Related]
14. Thymopentin treatment in genital warts of long duration. Fransen L; Anthoons J; Hoogewijs G; Bolla K Cancer Detect Prev; 1988; 12(1-6):503-9. PubMed ID: 3052838 [TBL] [Abstract][Full Text] [Related]
15. [Treatment with thymopentine of chronic bronchitis in elderly patients during seasonal prophylaxis]. Santagata A Clin Ter; 1990 Feb; 132(4):249-54. PubMed ID: 2140311 [TBL] [Abstract][Full Text] [Related]
16. [A case of juvenile rheumatoid arthritis treated with thymopentin]. Tucciarone L; Felici W; Greco L; Mechelli A Minerva Pediatr; 1989 Feb; 41(2):109-11. PubMed ID: 2661988 [TBL] [Abstract][Full Text] [Related]
17. [Use of thymopentin in the treatment of post-radiation cystitis]. Martinoli F; Catania G; Bertana F; Caldera G Minerva Urol Nefrol; 1988; 40(4):275-6. PubMed ID: 3075095 [No Abstract] [Full Text] [Related]
18. An immunomodulating drug, thymopentin, in the treatment of progressive systemic sclerosis. Giordano N; Biasi G; Taddeo A; Marcolongo R; Bertelletti D Clin Rheumatol; 1989 Jun; 8(2):293-4. PubMed ID: 2667863 [No Abstract] [Full Text] [Related]
19. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients. Mascart-Lemone F; Huygen K; Clumeck N; Brenez D; Bolla K; Duchateau J Lancet; 1983 Sep; 2(8352):735-6. PubMed ID: 6193382 [No Abstract] [Full Text] [Related]
20. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin]. Aiello A; Cristofaro M; Carrozza F; Di Rienzo G; Carile L Clin Ter; 1990 May; 133(4):227-31. PubMed ID: 2142910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]